Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

Data as of 11:49am ET
 -0.04 / -0.78%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Oramed Pharmaceuticals, Inc. is engaged in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides, such as insulin and vaccines. Its products are oral insulin and oral Exenatide capsules. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Contact Information

Oramed Pharmaceuticals, Inc.
Hi-Tech Park 2/5
Jerusalem -- 91390
P:(722) 566-0001
Investor Relations:



Other institutional6.26%
Mutual fund holders3.58%
Individual stakeholders23.30%

Top Executives

Nadav KidronPresident, Chief Executive Officer & Director
Joshua HexterChief Operating Officer & VP-Business Development
Yifat ZommerChief Financial Officer, Secretary & Treasurer
Miriam KidronDirector, CTO, Chief Medical & Scientific Officer
Roy EldorDirector-Medical Affairs

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.